Maze Therapeutics corporate secretary Courtney Phillips exercised Options for 11,000 shares at $0 per share on Sep 1, 2026, and held 11,000 shares afterward. The transaction matters to investors because it records the exercise price and Phillips’ post-transaction ownership in MAZE.
Key Highlights
- Courtney Phillips exercised options on Sep 1, 2026.
- The transaction included 11,000 derivative securities.
- Phillips held 11,000 derivative securities after the exercise.
Maze Therapeutics, Inc. (NASDAQ: MAZE) saw Courtney Phillips exercise options for 11,000 shares at $0 per share on Sep 1, 2026. Phillips, the company’s GC and Corp. Secretary, recorded ownership of 11,000 shares after the transaction.
Option Exercise Covers 11,000 Securities
The transaction involved options for 11,000 shares, with the exercise price listed at $0 per share. The transaction also covered 11,000 derivative securities. Following the exercise, Phillips owned 11,000 shares and 11,000 derivative securities.
Post-Transaction Ownership Recorded
The reported holdings distinguish between Maze Therapeutics shares and derivative securities. Each category was listed at 11,000 following the transaction. Following the Sep 1, 2026 exercise, Phillips owned 11,000 shares and 11,000 derivative securities.
FAQs
Q: What did Courtney Phillips exercise at Maze Therapeutics?
A: Courtney Phillips exercised options for 11,000 Maze Therapeutics shares at $0 per share on Sep 1, 2026. Phillips serves as GC and Corp. Secretary.
Q: How many MAZE shares did Courtney Phillips own after the transaction?
A: Courtney Phillips owned 11,000 Maze Therapeutics shares after the option exercise. The filing also reported 11,000 derivative securities after the transaction.
Q: What derivative securities did Courtney Phillips hold after the exercise?
A: The transaction record showed Courtney Phillips holding 11,000 Maze Therapeutics derivative securities after the exercise. Phillips also held 11,000 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.